| Entry |
|
|---|
| Name |
Mutation-caused aberrant SNCA to transport of dopamine
|
|---|
| Definition |
SNCA* -| VMAT2 |
|---|
| Expanded |
6622v1 -| 6571 |
|---|
| Class |
|
|---|
| Type |
Variant
|
|---|
| Pathway |
|
|---|
| Disease |
|
|---|
| Gene |
| 6622 | SNCA; synuclein alpha |
| 6571 | SLC18A2; solute carrier family 18 member A2 |
|
|---|
| Variant |
|
|---|
| Reference |
|
|---|
| Authors |
Jesko H, Lenkiewicz AM, Wilkaniec A, Adamczyk A |
|---|
| Title |
The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease. |
|---|
| Journal |
Acta Neurobiol Exp (Wars) 79:276-289 (2019) |
|---|
| Reference |
|
|---|
| Authors |
Guo JT, Chen AQ, Kong Q, Zhu H, Ma CM, Qin C |
|---|
| Title |
Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
